Genetics of attention-deficit hyperactivity disorder (ADHD)

Neuropharmacology

Volumn 57, Issue 7-8, 2009, Pages 590-600

  Sharp, Sally I ^a   McQuillin, Andrew ^a   Gurling, Hugh M D ^a  

^a Windeyer Institute   (United Kingdom)

Author keywords

Attention deficit hyperactivity disorder (ADHD); DAT1; DRD4; Linkage association

Indexed keywords

ALCOHOL; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 2A ADRENERGIC RECEPTOR; AMINE OXIDASE (FLAVIN CONTAINING); CADHERIN; CANNABINOID RECEPTOR; CATECHOL METHYLTRANSFERASE; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE BETA MONOOXYGENASE; DOPAMINE TRANSPORTER; INOSITOL 1,4,5 TRISPHOSPHATASE; KHELLIN; NICOTINIC RECEPTOR; PROTEIN TYROSINE PHOSPHATASE; SCLEROPROTEIN; SEROTONIN 1B RECEPTOR; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; TACHYKININ RECEPTOR; TRYPTOPHAN HYDROXYLASE; TRYPTOPHAN HYDROXYLASE 2;

ALCOHOLISM; ATTENTION DEFICIT DISORDER; AUTISM; CHROMOSOME 10Q; CHROMOSOME 12Q; CHROMOSOME 16P; CHROMOSOME 2Q; CHROMOSOME 5P; COMORBIDITY; CONDUCT DISORDER; ENVIRONMENTAL FACTOR; FAMILY STUDY; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HERITABILITY; HUMAN; LINKAGE ANALYSIS; MANIA; MOOD DISORDER; PRIORITY JOURNAL; PSYCHOPATHY; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SUBSTANCE ABUSE; TWINS;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HEREDITY; HUMANS; LINKAGE (GENETICS); TWIN STUDIES AS TOPIC;

EID: 70350223638     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.08.011     Document Type: Review

References (184)

1. Acosta M.T., Arcos-Burgos M., and Muenke M. Attention deficit/hyperactivity disorder (ADHD): complex phenotype, simple genotype?. Genet. Med. 6 (2004) 1-15
2. American-Psychiatric-Association. Diagnostic and Statistical Manual of Mental Disorders (1994), American Psychiatric Association, Washington, DC
3. Andrews G.D., and Lavin A. Methylphenidate increases cortical excitability via activation of alpha-2 noradrenergic receptors. Neuropsychopharmacology 31 (2006) 594-601
4. Arcos-Burgos M., Castellanos F.X., Pineda D., Lopera F., Palacio J.D., Palacio L.G., Rapoport J.L., Berg K., Bailey-Wilson J.E., and Muenke M. Attention-deficit/hyperactivity disorder in a population isolate: linkage to loci at 4q13.2, 5q33.3, 11q22, and 17p11. Am. J. Hum. Genet. 75 (2004) 998-1014
5. Asghari V., Sanyal S., Buchwaldt S., Paterson A., Jovanovic V., and Van Tol H.H. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J. Neurochem. 65 (1995) 1157-1165
6. Asherson P., Brookes K., Franke B., Chen W., Gill M., Ebstein R.P., Buitelaar J., Banaschewski T., Sonuga-Barke E., Eisenberg J., Manor I., Miranda A., Oades R.D., Roeyers H., Rothenberger A., Sergeant J., Steinhausen H.C., and Faraone S.V. Confirmation that a specific haplotype of the dopamine transporter gene is associated with combined-type ADHD. Am. J. Psychiatry 164 (2007) 674-677
7. Asherson P., Zhou K., Anney R.J., Franke B., Buitelaar J., Ebstein R., Gill M., Altink M., Arnold R., Boer F., Brookes K., Buschgens C., Butler L., Cambell D., Chen W., Christiansen H., Feldman L., Fleischman K., Fliers E., Howe-Forbes R., Goldfarb A., Heise A., Gabriels I., Johansson L., Lubetzki I., Marco R., Medad S., Minderaa R., Mulas F., Muller U., Mulligan A., Neale B., Rijsdijk F., Rabin K., Rommelse N., Sethna V., Sorohan J., Uebel H., Psychogiou L., Weeks A., Barrett R., Xu X., Banaschewski T., Sonuga-Barke E., Eisenberg J., Manor I., Miranda A., Oades R.D., Roeyers H., Rothenberger A., Sergeant J., Steinhausen H.C., Taylor E., Thompson M., and Faraone S.V. A high-density SNP linkage scan with 142 combined subtype ADHD sib pairs identifies linkage regions on chromosomes 9 and 16. Mol. Psychiatry 13 (2008) 514-521
8. Bakker S.C., van der Meulen E.M., Buitelaar J.K., Sandkuijl L.A., Pauls D.L., Monsuur A.J., van 't Slot R., Minderaa R.B., Gunning W.B., Pearson P.L., and Sinke R.J. A whole-genome scan in 164 Dutch sib pairs with attention-deficit/hyperactivity disorder: suggestive evidence for linkage on chromosomes 7p and 15q. Am. J. Hum. Genet. 72 (2003) 1251-1260
9. Bakker S.C., van der Meulen E.M., Oteman N., Schelleman H., Pearson P.L., Buitelaar J.K., and Sinke R.J. DAT1, DRD4, and DRD5 polymorphisms are not associated with ADHD in Dutch families. Am. J. Med. Genet. B Neuropsychiatr. Genet. 132B (2005) 50-52
10. Banoei M.M., Majidizadeh T., Shirazi E., Moghimi N., Ghadiri M., Najmabadi H., and Ohadi M. No association between the DAT1 10-repeat allele and ADHD in the Iranian population. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B (2008) 110-111
11. Barkley R.A., Smith K.M., Fischer M., and Navia B. An examination of the behavioral and neuropsychological correlates of three ADHD candidate gene polymorphisms (DRD4 7+, DBH TaqI A2, and DAT1 40 bp VNTR) in hyperactive and normal children followed to adulthood. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141B (2006) 487-498
12. Barr C.L., Feng Y., Wigg K.G., Schachar R., Tannock R., Roberts W., Malone M., and Kennedy J.L. 5′-Untranslated region of the dopamine D4 receptor gene and attention-deficit hyperactivity disorder. Am. J. Med. Genet. 105 (2001) 84-90
13. Barr C.L., Xu C., Kroft J., Feng Y., Wigg K., Zai G., Tannock R., Schachar R., Malone M., Roberts W., Nothen M.M., Grunhage F., Vandenbergh D.J., Uhl G., Sunohara G., King N., and Kennedy J.L. Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder. Biol. Psychiatry 49 (2001) 333-339
14. Battersby S., Ogilvie A.D., Blackwood D.H., Shen S., Muqit M.M., Muir W.J., Teague P., Goodwin G.M., and Harmar A.J. Presence of multiple functional polyadenylation signals and a single nucleotide polymorphism in the 3′ untranslated region of the human serotonin transporter gene. J. Neurochem. 72 (1999) 1384-1388
15. Bellgrove M.A., and Mattingley J.B. Molecular genetics of attention. Ann. NY Acad. Sci. 1129 (2008) 200-212
16. Biederman J., Munir K., Knee D., Armentano M., Autor S., Waternaux C., and Tsuang M. High rate of affective disorders in probands with attention deficit disorder and in their relatives: a controlled family study. Am. J. Psychiatry 144 (1987) 330-333
17. Biederman J., Faraone S.V., Keenan K., Knee D., and Tsuang M.T. Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder. J. Am. Acad. Child. Adolesc. Psychiatry 29 (1990) 526-533
18. Biederman J., Faraone S.V., Keenan K., and Tsuang M.T. Evidence of familial association between attention deficit disorder and major affective disorders. Arch. Gen. Psychiatry 48 (1991) 633-642
19. Biederman J., Newcorn J., and Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am. J. Psychiatry 148 (1991) 564-577
20. Biederman J., Faraone S.V., Hatch M., Mennin D., Taylor A., and George P. Conduct disorder with and without mania in a referred sample of ADHD children. J. Affect Disord. 44 (1997) 177-188
21. Biederman J., Mick E., Wozniak J., Monuteaux M.C., Galdo M., and Faraone S.V. Can a subtype of conduct disorder linked to bipolar disorder be identified? Integration of findings from the Massachusetts General Hospital Pediatric Psychopharmacology Research Program. Biol. Psychiatry 53 (2003) 952-960
22. Biederman J., Petty C.R., Byrne D., Wong P., Wozniak J., and Faraone S.V. Risk for switch from unipolar to bipolar disorder in youth with ADHD: a long term prospective controlled study. J. Affect Disord (2009)
23. Blum K., Noble E.P., Sheridan P.J., Finley O., Montgomery A., Ritchie T., Ozkaragoz T., Fitch R.J., Sadlack F., Sheffield D., et al. Association of the A1 allele of the D2 dopamine receptor gene with severe alcoholism. Alcohol 8 (1991) 409-416
24. Bobb A.J., Addington A.M., Sidransky E., Gornick M.C., Lerch J.P., Greenstein D.K., Clasen L.S., Sharp W.S., Inoff-Germain G., Wavrant-De Vrieze F., Arcos-Burgos M., Straub R.E., Hardy J.A., Castellanos F.X., and Rapoport J.L. Support for association between ADHD and two candidate genes: NET1 and DRD1. Am. J. Med. Genet. B Neuropsychiatr. Genet. 134B (2005) 67-72
25. Boonstra A.M., Kooij J.J., Buitelaar J.K., Oosterlaan J., Sergeant J.A., Heister J.G., and Franke B. An exploratory study of the relationship between four candidate genes and neurocognitive performance in adult ADHD. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147 (2008) 397-402
26. Bowden C.L., Deutsch C.K., and Swanson J.M. Plasma dopamine-beta-hydroxylase and platelet monoamine oxidase in attention deficit disorder and conduct disorder. J. Am. Acad. Child. Adolesc. Psychiatry 27 (1988) 171-174
27. Brookes K., Xu X., Chen W., Zhou K., Neale B., Lowe N., Anney R., Franke B., Gill M., Ebstein R., Buitelaar J., Sham P., Campbell D., Knight J., Andreou P., Altink M., Arnold R., Boer F., Buschgens C., Butler L., Christiansen H., Feldman L., Fleischman K., Fliers E., Howe-Forbes R., Goldfarb A., Heise A., Gabriels I., Korn-Lubetzki I., Johansson L., Marco R., Medad S., Minderaa R., Mulas F., Muller U., Mulligan A., Rabin K., Rommelse N., Sethna V., Sorohan J., Uebel H., Psychogiou L., Weeks A., Barrett R., Craig I., Banaschewski T., Sonuga-Barke E., Eisenberg J., Kuntsi J., Manor I., McGuffin P., Miranda A., Oades R.D., Plomin R., Roeyers H., Rothenberger A., Sergeant J., Steinhausen H.C., Taylor E., Thompson M., Faraone S.V., and Asherson P. The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol. Psychiatry 11 (2006) 934-953
28. Brookes K.J., Mill J., Guindalini C., Curran S., Xu X., Knight J., Chen C.K., Huang Y.S., Sethna V., Taylor E., Chen W., Breen G., and Asherson P. A common haplotype of the dopamine transporter gene associated with attention-deficit/hyperactivity disorder and interacting with maternal use of alcohol during pregnancy. Arch. Gen. Psychiatry 63 (2006) 74-81
29. Brophy K., Hawi Z., Kirley A., Fitzgerald M., and Gill M. Synaptosomal-associated protein 25 (SNAP-25) and attention deficit hyperactivity disorder (ADHD): evidence of linkage and association in the Irish population. Mol. Psychiatry 7 (2002) 913-917
30. Brunner H.G., Nelen M., Breakefield X.O., Ropers H.H., and van Oost B.A. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262 (1993) 578-580
31. Carrasco X., Rothhammer P., Moraga M., Henriquez H., Chakraborty R., Aboitiz F., and Rothhammer F. Genotypic interaction between DRD4 and DAT1 loci is a high risk factor for attention-deficit/hyperactivity disorder in Chilean families. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141B (2006) 51-54
32. Cheon K.A., Ryu Y.H., Kim J.W., and Cho D.Y. The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate. Eur. Neuropsychopharmacol. 15 (2005) 95-101
33. Cheuk D.K., Li S.Y., and Wong V. No association between VNTR polymorphisms of dopamine transporter gene and attention deficit hyperactivity disorder in Chinese children. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141B (2006) 123-125
34. Cichon S., Craddock N., Daly M., Faraone S.V., Gejman P.V., Kelsoe J., Lehner T., Levinson D.F., Moran A., Sklar P., and Sullivan P.F. Genomewide association studies: history, rationale, and prospects for psychiatric disorders. Am. J. Psychiatry 166 (2009) 540-556
35. Clure C., Brady K.T., Saladin M.E., Johnson D., Waid R., and Rittenbury M. Attention-deficit/hyperactivity disorder and substance use: symptom pattern and drug choice. Am. J. Drug Alcohol Abuse 25 (1999) 441-448
36. Cook Jr. E.H., Stein M.A., Krasowski M.D., Cox N.J., Olkon D.M., Kieffer J.E., and Leventhal B.L. Association of attention-deficit disorder and the dopamine transporter gene. Am. J. Hum. Genet. 56 (1995) 993-998
37. Cook C.C., Palsson G., Turner A., Holmes D., Brett P., Curtis D., Petursson H., and Gurling H.M. A genetic linkage study of the D2 dopamine receptor locus in heavy drinking and alcoholism. Br. J. Psychiatry 169 (1996) 243-248
38. Coolidge F.L., Thede L.L., and Young S.E. Heritability and the comorbidity of attention deficit hyperactivity disorder with behavioral disorders and executive function deficits: a preliminary investigation. Dev. Neuropsychol. 17 (2000) 273-287
39. Curran S., Mill J., Tahir E., Kent L., Richards S., Gould A., Huckett L., Sharp J., Batten C., Fernando S., Ozbay F., Yazgan Y., Simonoff E., Thompson M., Taylor E., and Asherson P. Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples. Mol. Psychiatry 6 (2001) 425-428
40. D'Souza U.M., Russ C., Tahir E., Mill J., McGuffin P., Asherson P.J., and Craig I.W. Functional effects of a tandem duplication polymorphism in the 5′flanking region of the DRD4 gene. Biol. Psychiatry 56 (2004) 691-697
41. Daly G., Hawi Z., Fitzgerald M., and Gill M. Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol. Psychiatry 4 (1999) 192-196
42. Das M., and Mukhopadhyay K. DAT1 3′-UTR 9R allele: preferential transmission in Indian children with attention deficit hyperactivity disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144B (2007) 826-829
43. Durston S. A review of the biological bases of ADHD: what have we learned from imaging studies?. Ment. Retard. Dev. Disabil. Res. Rev. 9 (2003) 184-195
44. Durston S., Fossella J.A., Casey B.J., Hulshoff Pol H.E., Galvan A., Schnack H.G., Steenhuis M.P., Minderaa R.B., Buitelaar J.K., Kahn R.S., and van Engeland H. Differential effects of DRD4 and DAT1 genotype on fronto-striatal gray matter volumes in a sample of subjects with attention deficit hyperactivity disorder, their unaffected siblings, and controls. Mol. Psychiatry 10 (2005) 678-685
45. Ebstein R.P., Novick O., Umansky R., Priel B., Osher Y., Blaine D., Bennett E.R., Nemanov L., Katz M., and Belmaker R.H. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nat. Genet. 12 (1996) 78-80
46. Elia J., Capasso M., Zaheer Z., Lantieri F., Ambrosini P., Berrettini W., Devoto M., and Hakonarson H. Candidate gene analysis in an on-going genome-wide association study of attention-deficit hyperactivity disorder: suggestive association signals in ADRA1A. Psychiatr. Genet. 19 (2009) 134-141
47. Elia J., Gai X., Xie H.M., Perin J.C., Geiger E., Glessner J.T., D'Arcy M., Deberardinis R., Frackelton E., Kim C., Lantieri F., Muganga B.M., Wang L., Takeda T., Rappaport E.F., Grant S.F., Berrettini W., Devoto M., Shaikh T.H., Hakonarson H., and White P.S. Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol. Psychiatry (2009)
48. Fagerheim T., Raeymaekers P., Tonnessen F.E., Pedersen M., Tranebjaerg L., and Lubs H.A. A new gene (DYX3) for dyslexia is located on chromosome 2. J. Med. Genet. 36 (1999) 664-669
49. Faraone S.V., Doyle A.E., Mick E., and Biederman J. Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am. J. Psychiatry 158 (2001) 1052-1057
50. Faraone S.V., Perlis R.H., Doyle A.E., Smoller J.W., Goralnick J.J., Holmgren M.A., and Sklar P. Molecular genetics of attention-deficit/hyperactivity disorder. Biol. Psychiatry 57 (2005) 1313-1323
51. Faraone S.V., Wilens T.E., Petty C., Antshel K., Spencer T., and Biederman J. Substance use among ADHD adults: implications of late onset and subthreshold diagnoses. Am. J. Addict. 16 Suppl 1 (2007) 24-32 quiz 33-24
52. Faraone S.V., Doyle A.E., Lasky-Su J., Sklar P.B., D'Angelo E., Gonzalez-Heydrich J., Kratochvil C., Mick E., Klein K., Rezac A.J., and Biederman J. Linkage analysis of attention deficit hyperactivity disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B (2008) 1387-1391
53. Fayyad J., De Graaf R., Kessler R., Alonso J., Angermeyer M., Demyttenaere K., De Girolamo G., Haro J.M., Karam E.G., Lara C., Lepine J.P., Ormel J., Posada-Villa J., Zaslavsky A.M., and Jin R. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br. J. Psychiatry 190 (2007) 402-409
54. Feng Y., Crosbie J., Wigg K., Pathare T., Ickowicz A., Schachar R., Tannock R., Roberts W., Malone M., Swanson J., Kennedy J.L., and Barr C.L. The SNAP25 gene as a susceptibility gene contributing to attention-deficit hyperactivity disorder. Mol. Psychiatry 10 (2005) 998-1005 1973
55. Feng Y., Wigg K.G., Makkar R., Ickowicz A., Pathare T., Tannock R., Roberts W., Malone M., Kennedy J.L., Schachar R., and Barr C.L. Sequence variation in the 3′-untranslated region of the dopamine transporter gene and attention-deficit hyperactivity disorder (ADHD). Am. J. Med. Genet. B Neuropsychiatr. Genet. 139B (2005) 1-6
56. Ferreira M.A., O'Donovan M.C., Meng Y.A., Jones I.R., Ruderfer D.M., Jones L., Fan J., Kirov G., Perlis R.H., Green E.K., Smoller J.W., Grozeva D., Stone J., Nikolov I., Chambert K., Hamshere M.L., Nimgaonkar V.L., Moskvina V., Thase M.E., Caesar S., Sachs G.S., Franklin J., Gordon-Smith K., Ardlie K.G., Gabriel S.B., Fraser C., Blumenstiel B., Defelice M., Breen G., Gill M., Morris D.W., Elkin A., Muir W.J., McGhee K.A., Williamson R., MacIntyre D.J., MacLean A.W., St C.D., Robinson M., Van Beck M., Pereira A.C., Kandaswamy R., McQuillin A., Collier D.A., Bass N.J., Young A.H., Lawrence J., Ferrier I.N., Anjorin A., Farmer A., Curtis D., Scolnick E.M., McGuffin P., Daly M.J., Corvin A.P., Holmans P.A., Blackwood D.H., Gurling H.M., Owen M.J., Purcell S.M., Sklar P., and Craddock N. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat. Genet. 40 (2008) 1056-1058
57. Fisher S.E., Francks C., McCracken J.T., McGough J.J., Marlow A.J., MacPhie I.L., Newbury D.F., Crawford L.R., Palmer C.G., Woodward J.A., Del'Homme M., Cantwell D.P., Nelson S.F., Monaco A.P., and Smalley S.L. A genomewide scan for loci involved in attention-deficit/hyperactivity disorder. Am. J. Hum. Genet. 70 (2002) 1183-1196
58. Fiskerstrand C.E., Lovejoy E.A., and Quinn J.P. An intronic polymorphic domain often associated with susceptibility to affective disorders has allele dependent differential enhancer activity in embryonic stem cells. FEBS Lett. 458 (1999) 171-174
59. Franke B., Neale B.M., and Faraone S.V. Genome-wide association studies in ADHD. Hum. Genet (2009)
60. Friedel S., Saar K., Sauer S., Dempfle A., Walitza S., Renner T., Romanos M., Freitag C., Seitz C., Palmason H., Scherag A., Windemuth-Kieselbach C., Schimmelmann B.G., Wewetzer C., Meyer J., Warnke A., Lesch K.P., Reinhardt R., Herpertz-Dahlmann B., Linder M., Hinney A., Remschmidt H., Schafer H., Konrad K., Hubner N., and Hebebrand J. Association and linkage of allelic variants of the dopamine transporter gene in ADHD. Mol. Psychiatry 12 (2007) 923-933
61. Galili-Weisstub E., and Segman R.H. Attention deficit and hyperactivity disorder: review of genetic association studies. Isr. J. Psychiatry Relat. Sci. 40 (2003) 57-66
62. Genro J.P., Zeni C., Polanczyk G.V., Roman T., Rohde L.A., and Hutz M.H. A promoter polymorphism (-839 C > T) at the dopamine transporter gene is associated with attention deficit/hyperactivity disorder in Brazilian children. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144B (2007) 215-219
63. Genro J.P., Polanczyk G.V., Zeni C., Oliveira A.S., Roman T., Rohde L.A., and Hutz M.H. A common haplotype at the dopamine transporter gene 5′ region is associated with attention-deficit/hyperactivity disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B (2008) 1568-1575
64. Ghebranious N., Giampietro P.F., Wesbrook F.P., and Rezkalla S.H. A novel microdeletion at 16p11.2 harbors candidate genes for aortic valve development, seizure disorder, and mild mental retardation. Am. J. Med. Genet. A 143A (2007) 1462-1471
65. Gizer I.R., Ficks C., and Waldman I.D. Candidate gene studies of ADHD: a meta-analytic review. Hum. Genet (2009)
66. Gruber R., Joober R., Grizenko N., Leventhal B.L., Cook Jr. E.H., and Stein M.A. Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder. J. Child. Adolesc. Psychopharmacol. 19 (2009) 233-239
67. Guan L., Wang B., Chen Y., Yang L., Li J., Qian Q., Wang Z., Faraone S.V., and Wang Y. A high-density single-nucleotide polymorphism screen of 23 candidate genes in attention deficit hyperactivity disorder: suggesting multiple susceptibility genes among Chinese Han population. Mol. Psychiatry 14 (2009) 546-554
68. Hawi Z., Dring M., Kirley A., Foley D., Kent L., Craddock N., Asherson P., Curran S., Gould A., Richards S., Lawson D., Pay H., Turic D., Langley K., Owen M., O'Donovan M., Thapar A., Fitzgerald M., and Gill M. Serotonergic system and attention deficit hyperactivity disorder (ADHD): a potential susceptibility locus at the 5-HT(1B) receptor gene in 273 nuclear families from a multi-centre sample. Mol. Psychiatry 7 (2002) 718-725
69. Hawi Z., Lowe N., Kirley A., Gruenhage F., Nothen M., Greenwood T., Kelsoe J., Fitzgerald M., and Gill M. Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci. Mol. Psychiatry 8 (2003) 299-308
70. Hawi Z., Segurado R., Conroy J., Sheehan K., Lowe N., Kirley A., Shields D., Fitzgerald M., Gallagher L., and Gill M. Preferential transmission of paternal alleles at risk genes in attention-deficit/hyperactivity disorder. Am. J. Hum. Genet. 77 (2005) 958-965
71. Hebebrand J., Dempfle A., Saar K., Thiele H., Herpertz-Dahlmann B., Linder M., Kiefl H., Remschmidt H., Hemminger U., Warnke A., Knolker U., Heiser P., Friedel S., Hinney A., Schafer H., Nurnberg P., and Konrad K. A genome-wide scan for attention-deficit/hyperactivity disorder in 155 German sib-pairs. Mol. Psychiatry 11 (2006) 196-205
72. Henin A., Mick E., Biederman J., Fried R., Wozniak J., Faraone S.V., Harrington K., Davis S., and Doyle A.E. Can bipolar disorder-specific neuropsychological impairments in children be identified?. J. Consult. Clin. Psychol. 75 (2007) 210-220
73. Hirshfeld-Becker D.R., Biederman J., Henin A., Faraone S.V., Dowd S.T., De Petrillo L.A., Markowitz S.M., and Rosenbaum J.F. Psychopathology in the young offspring of parents with bipolar disorder: a controlled pilot study. Psychiatry Res. 145 (2006) 155-167
74. Hirvonen M., Laakso A., Nagren K., Rinne J.O., Pohjalainen T., and Hietala J. C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo. Mol. Psychiatry 9 (2004) 1060-1061
75. Hofvander B., Ossowski D., Lundstrom S., and Anckarsater H. Continuity of aggressive antisocial behavior from childhood to adulthood: the question of phenotype definition. Int. J. Law Psychiatry 32 (2009) 224-234
76. Jaideep T., Reddy Y.C., and Srinath S. Comorbidity of attention deficit hyperactivity disorder in juvenile bipolar disorder. Bipolar Disord. 8 (2006) 182-187
77. Jiang S.D., He M., Qian Y.P., Wang D.X., Zhang Y., Li F., Tian H.J., Xin R.E., Tang G.M., and Wu X.D. [Genome-wide search for linkage to attention deficit hyperactivity disorder (ADHD) on the X chromosome]. Yi Chuan 28 (2006) 26-30
78. Kent L., Middle F., Hawi Z., Fitzgerald M., Gill M., Feehan C., and Craddock N. Nicotinic acetylcholine receptor alpha4 subunit gene polymorphism and attention deficit hyperactivity disorder. Psychiatr. Genet. 11 (2001) 37-40
79. Kereszturi E., Kiraly O., Csapo Z., Tarnok Z., Gadoros J., Sasvari-Szekely M., and Nemoda Z. Association between the 120-bp duplication of the dopamine D4 receptor gene and attention deficit hyperactivity disorder: genetic and molecular analyses. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144B (2007) 231-236
80. Kessler R.C., Adler L., Barkley R., Biederman J., Conners C.K., Demler O., Faraone S.V., Greenhill L.L., Howes M.J., Secnik K., Spencer T., Ustun T.B., Walters E.E., and Zaslavsky A.M. The prevalence and correlates of adult ADHD in the United States: results from the national comorbidity Survey replication. Am. J. Psychiatry 163 (2006) 716-723
81. Kim Y.S., Leventhal B.L., Kim S.J., Kim B.N., Cheon K.A., Yoo H.J., Kim S.J., Badner J., and Cook E.H. Family-based association study of DAT1 and DRD4 polymorphism in Korean children with ADHD. Neurosci. Lett. 390 (2005) 176-181
82. Kim J.W., Kim B.N., and Cho S.C. The dopamine transporter gene and the impulsivity phenotype in attention deficit hyperactivity disorder: a case-control association study in a Korean sample. J. Psychiatr. Res. 40 (2006) 730-737
83. Kopeckova M., Paclt I., Petrasek J., Pacltova D., Malikova M., and Zagatova V. Some ADHD polymorphisms (in genes DAT1, DRD2, DRD3, DBH, 5-HTT) in case-control study of 100 subjects 6-10 age. Neuro Endocrinol. Lett. 29 (2008) 246-251
84. Kuntsi J., Eley T.C., Taylor A., Hughes C., Asherson P., Caspi A., and Moffitt T.E. Co-occurrence of ADHD and low IQ has genetic origins. Am. J. Med. Genet. B Neuropsychiatr. Genet. 124B (2004) 41-47
85. Kuntsi J., Neale B.M., Chen W., Faraone S.V., and Asherson P. The IMAGE project: methodological issues for the molecular genetic analysis of ADHD. Behav. Brain Funct. 2 (2006) 27
86. Kustanovich V., Ishii J., Crawford L., Yang M., McGough J.J., McCracken J.T., Smalley S.L., and Nelson S.F. Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5. Mol. Psychiatry 9 (2004) 711-717
87. Langley K., Marshall L., van den Bree M., Thomas H., Owen M., O'Donovan M., and Thapar A. Association of the dopamine D4 receptor gene 7-repeat allele with neuropsychological test performance of children with ADHD. Am. J. Psychiatry 161 (2004) 133-138
88. Langley K., Turic D., Peirce T.R., Mills S., Van Den Bree M.B., Owen M.J., O'Donovan M.C., and Thapar A. No support for association between the dopamine transporter (DAT1) gene and ADHD. Am. J. Med. Genet. B Neuropsychiatr. Genet. 139B (2005) 7-10
89. Lasky-Su J., Lange C., Biederman J., Tsuang M., Doyle A.E., Smoller J.W., Laird N., and Faraone S. Family-based association analysis of a statistically derived quantitative traits for ADHD reveal an association in DRD4 with inattentive symptoms in ADHD individuals. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B (2008) 100-106
90. Lasky-Su J., Neale B.M., Franke B., Anney R.J., Zhou K., Maller J.B., Vasquez A.A., Chen W., Asherson P., Buitelaar J., Banaschewski T., Ebstein R., Gill M., Miranda A., Mulas F., Oades R.D., Roeyers H., Rothenberger A., Sergeant J., Sonuga-Barke E., Steinhausen H.C., Taylor E., Daly M., Laird N., Lange C., and Faraone S.V. Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B (2008) 1345-1354
91. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Muller C.R., Hamer D.H., and Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274 (1996) 1527-1531
92. Lesch K.P., Timmesfeld N., Renner T.J., Halperin R., Roser C., Nguyen T.T., Craig D.W., Romanos J., Heine M., Meyer J., Freitag C., Warnke A., Romanos M., Schafer H., Walitza S., Reif A., Stephan D.A., and Jacob C. Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. J. Neural Transm. 115 (2008) 1573-1585
93. Leung P.W., Lee C.C., Hung S.F., Ho T.P., Tang C.P., Kwong S.L., Leung S.Y., Yuen S.T., Lieh-Mak F., Oosterlaan J., Grady D., Harxhi A., Ding Y.C., Chi H.C., Flodman P., Schuck S., Spence M.A., Moyzis R., and Swanson J. Dopamine receptor D4 (DRD4) gene in Han Chinese children with attention-deficit/hyperactivity disorder (ADHD): increased prevalence of the 2-repeat allele. Am. J. Med. Genet. B Neuropsychiatr. Genet. 133B (2005) 54-56
94. Levin E.D., Conners C.K., Silva D., Canu W., and March J. Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder. Exp. Clin. Psychopharmacol. 9 (2001) 83-90
95. Li D., Sham P.C., Owen M.J., and He L. Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Hum. Mol. Genet. 15 (2006) 2276-2284
96. Li J., Wang Y., Zhou R., Zhang H., Yang L., Wang B., and Faraone S.V. Association between tryptophan hydroxylase gene polymorphisms and attention deficit hyperactivity disorder in Chinese Han population. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141B (2006) 126-129
97. Lim M.H., Kim H.W., Paik K.C., Cho S.C., Yoon D.Y., and Lee H.J. Association of the DAT1 polymorphism with attention deficit hyperactivity disorder (ADHD): a family-based approach. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141B (2006) 309-311
98. Loo S.K., Specter E., Smolen A., Hopfer C., Teale P.D., and Reite M.L. Functional effects of the DAT1 polymorphism on EEG measures in ADHD. J. Am. Acad. Child. Adolesc. Psychiatry 42 (2003) 986-993
99. Loo S.K., Fisher S.E., Francks C., Ogdie M.N., MacPhie I.L., Yang M., McCracken J.T., McGough J.J., Nelson S.F., Monaco A.P., and Smalley S.L. Genome-wide scan of reading ability in affected sibling pairs with attention-deficit/hyperactivity disorder: unique and shared genetic effects. Mol. Psychiatry 9 (2004) 485-493
100. Loo S.K., Hale T.S., Macion J., Hanada G., McGough J.J., McCracken J.T., and Smalley S.L. Cortical activity patterns in ADHD during arousal, activation and sustained attention. Neuropsychologia 47 (2009) 2114-2119
101. Lotrich F.E., and Pollock B.G. Meta-analysis of serotonin transporter polymorphisms and affective disorders. Psychiatr. Genet. 14 (2004) 121-129
102. Lott D.C., Kim S.J., Cook Jr. E.H., and de Wit H. Dopamine transporter gene associated with diminished subjective response to amphetamine. Neuropsychopharmacology 30 (2005) 602-609
103. Lowe N., Kirley A., Hawi Z., Sham P., Wickham H., Kratochvil C.J., Smith S.D., Lee S.Y., Levy F., Kent L., Middle F., Rohde L.A., Roman T., Tahir E., Yazgan Y., Asherson P., Mill J., Thapar A., Payton A., Todd R.D., Stephens T., Ebstein R.P., Manor I., Barr C.L., Wigg K.G., Sinke R.J., Buitelaar J.K., Smalley S.L., Nelson S.F., Biederman J., Faraone S.V., and Gill M. Joint analysis of the DRD5 marker concludes association with attention-deficit/hyperactivity disorder confined to the predominantly inattentive and combined subtypes. Am. J. Hum. Genet. 74 (2004) 348-356
104. Lowe N., Kirley A., Mullins C., Fitzgerald M., Gill M., and Hawi Z. Multiple marker analysis at the promoter region of the DRD4 gene and ADHD: evidence of linkage and association with the SNP -616. Am. J. Med. Genet. B Neuropsychiatr. Genet. 131B (2004) 33-37
105. Lu Y.M., Jia Z., Janus C., Henderson J.T., Gerlai R., Wojtowicz J.M., and Roder J.C. Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP. J. Neurosci. 17 (1997) 5196-5205
106. Lu A.T., Ogdie M.N., Jarvelin M.R., Moilanen I.K., Loo S.K., McCracken J.T., McGough J.J., Yang M.H., Peltonen L., Nelson S.F., Cantor R.M., and Smalley S.L. Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B (2008) 1488-1494
107. Lunetta K.L., Faraone S.V., Biederman J., and Laird N.M. Family-based tests of association and linkage that use unaffected sibs, covariates, and interactions. Am. J. Hum. Genet. 66 (2000) 605-614
108. Lynn D.E., Lubke G., Yang M., McCracken J.T., McGough J.J., Ishii J., Loo S.K., Nelson S.F., and Smalley S.L. Temperament and character profiles and the dopamine D4 receptor gene in ADHD. Am. J. Psychiatry 162 (2005) 906-913
109. MacKenzie A., and Quinn J. A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proc. Natl. Acad. Sci. USA 96 (1999) 15251-15255
110. Maher B.S., Marazita M.L., Ferrell R.E., and Vanyukov M.M. Dopamine system genes and attention deficit hyperactivity disorder: a meta-analysis. Psychiatr. Genet. 12 (2002) 207-215
111. Makris N., Biederman J., Valera E.M., Bush G., Kaiser J., Kennedy D.N., Caviness V.S., Faraone S.V., and Seidman L.J. Cortical thinning of the attention and executive function networks in adults with attention-deficit/hyperactivity disorder. Cereb. Cortex 17 (2007) 1364-1375
112. Mannuzza S., Klein R.G., Bonagura N., Malloy P., Giampino T.L., and Addalli K.A. Hyperactive boys almost grown up. V. Replication of psychiatric status. Arch. Gen. Psychiatry 48 (1991) 77-83
113. Manolio T.A., Rodriguez L.L., Brooks L., Abecasis G., Ballinger D., Daly M., Donnelly P., Faraone S.V., Frazer K., Gabriel S., Gejman P., Guttmacher A., Harris E.L., Insel T., Kelsoe J.R., Lander E., McCowin N., Mailman M.D., Nabel E., Ostell J., Pugh E., Sherry S., Sullivan P.F., Thompson J.F., Warram J., Wholley D., Milos P.M., and Collins F.S. New models of collaboration in genome-wide association studies: the genetic association information network. Nat. Genet. 39 (2007) 1045-1051
114. Manor I., Tyano S., Eisenberg J., Bachner-Melman R., Kotler M., and Ebstein R.P. The short DRD4 repeats confer risk to attention deficit hyperactivity disorder in a family-based design and impair performance on a continuous performance test (TOVA). Mol. Psychiatry 7 (2002) 790-794
115. Manuck S.B., Flory J.D., Ferrell R.E., Mann J.J., and Muldoon M.F. A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity. Psychiatry Res. 95 (2000) 9-23
116. Masi G., Perugi G., Toni C., Millepiedi S., Mucci M., Bertini N., and Pfanner C. Attention-deficit hyperactivity disorder - bipolar comorbidity in children and adolescents. Bipolar Disord. 8 (2006) 373-381
117. McCracken J.T., Smalley S.L., McGough J.J., Crawford L., Del'Homme M., Cantor R.M., Liu A., and Nelson S.F. Evidence for linkage of a tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4) with attention deficit hyperactivity disorder (ADHD). Mol. Psychiatry 5 (2000) 531-536
118. McLoughlin G., Ronald A., Kuntsi J., Asherson P., and Plomin R. Genetic support for the dual nature of attention deficit hyperactivity disorder: substantial genetic overlap between the inattentive and hyperactive-impulsive components. J. Abnorm. Child. Psychol. 35 (2007) 999-1008
119. Merikangas K.R., Leckman J.F., Prusoff B.A., Pauls D.L., and Weissman M.M. Familial transmission of depression and alcoholism. Arch. Gen. Psychiatry 42 (1985) 367-372
120. Merikangas K.R., and Gelernter C.S. Comorbidity for alcoholism and depression. Psychiatr. Clin. North Am. 13 (1990) 613-632
121. Mick E., Wozniak J., Wilens T.E., Biederman J., and Faraone S.V. Family-based association study of the BDNF, COMT and serotonin transporter genes and DSM-IV bipolar-I disorder in children. BMC Psychiatry 9 (2009) 2
122. Milin R., Halikas J.A., Meller J.E., and Morse C. Psychopathology among substance abusing juvenile offenders. J. Am. Acad. Child. Adolesc. Psychiatry 30 (1991) 569-574
123. Mulligan A., Anney R.J., O'Regan M., Chen W., Butler L., Fitzgerald M., Buitelaar J., Steinhausen H.C., Rothenberger A., Minderaa R., Nijmeijer J., Hoekstra P.J., Oades R.D., Roeyers H., Buschgens C., Christiansen H., Franke B., Gabriels I., Hartman C., Kuntsi J., Marco R., Meidad S., Mueller U., Psychogiou L., Rommelse N., Thompson M., Uebel H., Banaschewski T., Ebstein R., Eisenberg J., Manor I., Miranda A., Mulas F., Sergeant J., Sonuga-Barke E., Asherson P., Faraone S.V., and Gill M. Autism symptoms in Attention-Deficit/Hyperactivity Disorder: a familial trait which correlates with conduct, oppositional defiant, language and motor disorders. J. Autism Dev. Disord. 39 (2009) 197-209
124. Munafo M.R., Clark T.G., Roberts K.H., and Johnstone E.C. Neuroticism mediates the association of the serotonin transporter gene with lifetime major depression. Neuropsychobiology 53 (2006) 1-8
125. Neale B.M., Lasky-Su J., Anney R., Franke B., Zhou K., Maller J.B., Vasquez A.A., Asherson P., Chen W., Banaschewski T., Buitelaar J., Ebstein R., Gill M., Miranda A., Oades R.D., Roeyers H., Rothenberger A., Sergeant J., Steinhausen H.C., Sonuga-Barke E., Mulas F., Taylor E., Laird N., Lange C., Daly M., and Faraone S.V. Genome-wide association scan of attention deficit hyperactivity disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B (2008) 1337-1344
126. O'Neill M.F., Heron-Maxwell C.L., and Shaw G. 5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB. Pharmacol. Biochem. Behav. 63 (1999) 237-243
127. Ogdie M.N., Macphie I.L., Minassian S.L., Yang M., Fisher S.E., Francks C., Cantor R.M., McCracken J.T., McGough J.J., Nelson S.F., Monaco A.P., and Smalley S.L. A genomewide scan for attention-deficit/hyperactivity disorder in an extended sample: suggestive linkage on 17p11. Am. J. Hum. Genet. 72 (2003) 1268-1279
128. Ogdie M.N., Fisher S.E., Yang M., Ishii J., Francks C., Loo S.K., Cantor R.M., McCracken J.T., McGough J.J., Smalley S.L., and Nelson S.F. Attention deficit hyperactivity disorder: fine mapping supports linkage to 5p13, 6q12, 16p13, and 17p11. Am. J. Hum. Genet. 75 (2004) 661-668
129. Ohannessian C.M., Stabenau J.R., and Hesselbrock V.M. Childhood and adulthood temperament and problem behaviors and adulthood substance use. Addict. Behav. 20 (1995) 77-86
130. Ohlmeier M.D., Peters K., Te Wildt B.T., Zedler M., Ziegenbein M., Wiese B., Emrich H.M., and Schneider U. Comorbidity of alcohol and substance dependence with attention-deficit/hyperactivity disorder (ADHD). Alcohol Alcohol. 43 (2008) 300-304
131. Okuyama Y., Ishiguro H., Toru M., and Arinami T. A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia. Biochem. Biophys. Res. Commun. 258 (1999) 292-295
132. Ouellet-Morin I., Wigg K.G., Feng Y., Dionne G., Robaey P., Brendgen M., Vitaro F., Simard L., Schachar R., Tremblay R.E., Perusse D., Boivin M., and Barr C.L. Association of the dopamine transporter gene and ADHD symptoms in a Canadian population-based sample of same-age twins. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B (2008) 1442-1449
133. Pacholczyk T., Blakely R.D., and Amara S.G. Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 350 (1991) 350-354
134. Pastor P.N., and Reuben C.A. Diagnosed attention deficit hyperactivity disorder and learning disability: United States, 2004-2006. Vital Health Stat. 10 (2008) 1-14
135. Patel S.D., Chen C.P., Bahna F., Honig B., and Shapiro L. Cadherin-mediated cell-cell adhesion: sticking together as a family. Curr. Opin. Struct. Biol. 13 (2003) 690-698
136. Payton A., Holmes J., Barrett J.H., Hever T., Fitzpatrick H., Trumper A.L., Harrington R., McGuffin P., O'Donovan M., Owen M., Ollier W., Worthington J., and Thapar A. Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: a family-based study. Am. J. Med. Genet. 105 (2001) 464-470
137. Polanczyk G., de Lima M.S., Horta B.L., Biederman J., and Rohde L.A. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am. J. Psychiatry 164 (2007) 942-948
138. Ponce G., Hoenicka J., Rubio G., Ampuero I., Jimenez-Arriero M.A., Rodriguez-Jimenez R., Palomo T., and Ramos J.A. Association between cannabinoid receptor gene (CNR1) and childhood attention deficit/hyperactivity disorder in Spanish male alcoholic patients. Mol. Psychiatry 8 (2003) 466-467
139. Ponce G., Hoenicka J., Rodriguez-Jimenez R., Gozalo A., Jimenez M., Monasor R., Aragues M., Rubio G., Jimenez-Arriero M.A., Ramos J.A., and Palomo T. DRD2 TaqIA polymorphism is associated with urinary homovanillic acid levels in a sample of Spanish male alcoholic patients. Neurotox. Res. 6 (2004) 373-377
140. Ponce G., Hoenicka J., Jimenez-Arriero M.A., Rodriguez-Jimenez R., Aragues M., Martin-Sune N., Huertas E., and Palomo T. DRD2 and ANKK1 genotype in alcohol-dependent patients with psychopathic traits: association and interaction study. Br. J. Psychiatry 193 (2008) 121-125
141. Pottenger M., McKernon J., Patrie L.E., Weissman M.M., Ruben H.L., and Newberry P. The frequency and persistence of depressive symptoms in the alcohol abuser. J. Nerv. Ment. Dis. 166 (1978) 562-570
142. Preisig M., Fenton B.T., Stevens D.E., and Merikangas K.R. Familial relationship between mood disorders and alcoholism. Compr. Psychiatry 42 (2001) 87-95
143. Qian Q.J., Wang Y.F., Zhou R.L., Yang L., and Li J. Association studies of G352A polymorphism of dopamine transporter gene in Han Chinese attention deficit hyperactivity disorder patients. Beijing Da Xue Xue Bao 36 (2004) 626-629
144. Quist J.F., Barr C.L., Schachar R., Roberts W., Malone M., Tannock R., Basile V.S., Beitchman J., and Kennedy J.L. The serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder. Mol. Psychiatry 8 (2003) 98-102
145. Reiersen A.M., Constantino J.N., Volk H.E., and Todd R.D. Autistic traits in a population-based ADHD twin sample. J. Child. Psychol. Psychiatry 48 (2007) 464-472
146. Reiersen A.M., Constantino J.N., Grimmer M., Martin N.G., and Todd R.D. Evidence for shared genetic influences on self-reported ADHD and autistic symptoms in young adult Australian twins. Twin Res. Hum. Genet. 11 (2008) 579-585
147. Reif A. Is NOS1 a genetic link between RLS and ADHD?. J. Psychiatr. Res (2009)
148. Reif A., Herterich S., Strobel A., Ehlis A.C., Saur D., Jacob C.P., Wienker T., Topner T., Fritzen S., Walter U., Schmitt A., Fallgatter A.J., and Lesch K.P. A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol. Psychiatry 11 (2006) 286-300
149. Reif A., Jacob C.P., Rujescu D., Herterich S., Lang S., Gutknecht L., Baehne C.G., Strobel A., Freitag C.M., Giegling I., Romanos M., Hartmann A., Rosler M., Renner T.J., Fallgatter A.J., Retz W., Ehlis A.C., and Lesch K.P. Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans. Arch. Gen. Psychiatry 66 (2009) 41-50
150. Rietveld M.J., Hudziak J.J., Bartels M., van Beijsterveldt C.E., and Boomsma D.I. Heritability of attention problems in children: I. cross-sectional results from a study of twins, age 3-12 years. Am. J. Med. Genet. B Neuropsychiatr. Genet. 117B (2003) 102-113
151. Rietveld M.J., Hudziak J.J., Bartels M., van Beijsterveldt C.E., and Boomsma D.I. Heritability of attention problems in children: longitudinal results from a study of twins, age 3 to 12. J. Child. Psychol. Psychiatry 45 (2004) 577-588
152. Roman T., Schmitz M., Polanczyk G.V., Eizirik M., Rohde L.A., and Hutz M.H. Is the alpha-2A adrenergic receptor gene (ADRA2A) associated with attention-deficit/hyperactivity disorder?. Am. J. Med. Genet. B Neuropsychiatr. Genet. 120B (2003) 116-120
153. Roman T., Polanczyk G.V., Zeni C., Genro J.P., Rohde L.A., and Hutz M.H. Further evidence of the involvement of alpha-2A-adrenergic receptor gene (ADRA2A) in inattentive dimensional scores of attention-deficit/hyperactivity disorder. Mol. Psychiatry 11 (2006) 8-10
154. Romanos M., Freitag C., Jacob C., Craig D.W., Dempfle A., Nguyen T.T., Halperin R., Walitza S., Renner T.J., Seitz C., Romanos J., Palmason H., Reif A., Heine M., Windemuth-Kieselbach C., Vogler C., Sigmund J., Warnke A., Schafer H., Meyer J., Stephan D.A., and Lesch K.P. Genome-wide linkage analysis of ADHD using high-density SNP arrays: novel loci at 5q13.1 and 14q12. Mol. Psychiatry 13 (2008) 522-530
155. Rowe D.C., Van den Oord E.J., Stever C., Giedinghagen L.N., Gard J.M., Cleveland H.H., Gilson M., Terris S.T., Mohr J.H., Sherman S., Abramowitz A., and Waldman I.D. The DRD2 TaqI polymorphism and symptoms of attention deficit hyperactivity disorder. Mol. Psychiatry 4 (1999) 580-586
156. Rubino I.A., Frank E., Croce Nanni R., Pozzi D., Lanza di Scalea T., and Siracusano A. A Comparative study of Axis I Antecedents before age 18 of unipolar depression, bipolar disorder and schizophrenia. Psychopathology 42 (2009) 325-332
157. Schinka J.A., Busch R.M., and Robichaux-Keene N. A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety. Mol. Psychiatry 9 (2004) 197-202
158. Sheehan K., Lowe N., Kirley A., Mullins C., Fitzgerald M., Gill M., and Hawi Z. Tryptophan hydroxylase 2 (TPH2) gene variants associated with ADHD. Mol. Psychiatry 10 (2005) 944-949
159. Shiow L.R., Paris K., Akana M.C., Cyster J.G., Sorensen R.U., and Puck J.M. Severe combined immunodeficiency (SCID) and attention deficit hyperactivity disorder (ADHD) associated with a Coronin-1A mutation and a chromosome 16p11.2 deletion. Clin. Immunol. 131 (2009) 24-30
160. Simon V., Czobor P., Balint S., Meszaros A., and Bitter I. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br. J. Psychiatry 194 (2009) 204-211
161. Simsek M., Al-Sharbati M., Al-Adawi S., and Lawatia K. The VNTR polymorphism in the human dopamine transporter gene: improved detection and absence of association of VNTR alleles with attention-deficit hyperactivity disorder. Genet. Test. 10 (2006) 31-34
162. Smalley S.L., Kustanovich V., Minassian S.L., Stone J.L., Ogdie M.N., McGough J.J., McCracken J.T., MacPhie I.L., Francks C., Fisher S.E., Cantor R.M., Monaco A.P., and Nelson S.F. Genetic linkage of attention-deficit/hyperactivity disorder on chromosome 16p13, in a region implicated in autism. Am. J. Hum. Genet. 71 (2002) 959-963
163. Smith K.M., Daly M., Fischer M., Yiannoutsos C.T., Bauer L., Barkley R., and Navia B.A. Association of the dopamine beta hydroxylase gene with attention deficit hyperactivity disorder: genetic analysis of the Milwaukee longitudinal study. Am. J. Med. Genet. B Neuropsychiatr. Genet. 119B (2003) 77-85
164. Smoller J.W., Biederman J., Arbeitman L., Doyle A.E., Fagerness J., Perlis R.H., Sklar P., and Faraone S.V. Association between the 5HT1B receptor gene (HTR1B) and the inattentive subtype of ADHD. Biol. Psychiatry 59 (2006) 460-467
165. Solanto M.V. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav. Brain Res. 94 (1998) 127-152
166. Sonuga-Barke E.J., Lasky-Su J., Neale B.M., Oades R., Chen W., Franke B., Buitelaar J., Banaschewski T., Ebstein R., Gill M., Anney R., Miranda A., Mulas F., Roeyers H., Rothenberger A., Sergeant J., Steinhausen H.C., Thompson M., Asherson P., and Faraone S.V. Does parental expressed emotion moderate genetic effects in ADHD? An exploration using a genome wide association scan. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B (2008) 1359-1368
167. Sprich S., Biederman J., Crawford M.H., Mundy E., and Faraone S.V. Adoptive and biological families of children and adolescents with ADHD. J. Am. Acad. Child. Adolesc. Psychiatry 39 (2000) 1432-1437
168. Swanson J.M., Flodman P., Kennedy J., Spence M.A., Moyzis R., Schuck S., Murias M., Moriarity J., Barr C., Smith M., and Posner M. Dopamine genes and ADHD. Neurosci. Biobehav. Rev. 24 (2000) 21-25
169. Takeuchi T., Misaki A., Liang S.B., Tachibana A., Hayashi N., Sonobe H., and Ohtsuki Y. Expression of T-cadherin (CDH13, H-Cadherin) in human brain and its characteristics as a negative growth regulator of epidermal growth factor in neuroblastoma cells. J. Neurochem. 74 (2000) 1489-1497
170. Thapar A., Langley K., Fowler T., Rice F., Turic D., Whittinger N., Aggleton J., Van den Bree M., Owen M., and O'Donovan M. Catechol O-methyltransferase gene variant and birth weight predict early-onset antisocial behavior in children with attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry 62 (2005) 1275-1278
171. Todd R.D., Jong Y.J., Lobos E.A., Reich W., Heath A.C., and Neuman R.J. No association of the dopamine transporter gene 3′ VNTR polymorphism with ADHD subtypes in a population sample of twins. Am. J. Med. Genet. 105 (2001) 745-748
172. Uhl G.R., Drgon T., Liu Q.R., Johnson C., Walther D., Komiyama T., Harano M., Sekine Y., Inada T., Ozaki N., Iyo M., Iwata N., Yamada M., Sora I., Chen C.K., Liu H.C., Ujike H., and Lin S.K. Genome-wide association for methamphetamine dependence: convergent results from 2 samples. Arch. Gen. Psychiatry 65 (2008) 345-355
173. van 't Ent D., Lehn H., Derks E.M., Hudziak J.J., Van Strien N.M., Veltman D.J., De Geus E.J., Todd R.D., and Boomsma D.I. A structural MRI study in monozygotic twins concordant or discordant for attention/hyperactivity problems: evidence for genetic and environmental heterogeneity in the developing brain. Neuroimage 35 (2007) 1004-1020
174. Waldman I.D., Rowe D.C., Abramowitz A., Kozel S.T., Mohr J.H., Sherman S.L., Cleveland H.H., Sanders M.L., Gard J.M., and Stever C. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Am. J. Hum. Genet. 63 (1998) 1767-1776
175. Walitza S., Renner T.J., Dempfle A., Konrad K., Wewetzer C., Halbach A., Herpertz-Dahlmann B., Remschmidt H., Smidt J., Linder M., Flierl L., Knolker U., Friedel S., Schafer H., Gross C., Hebebrand J., Warnke A., and Lesch K.P. Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in attention-deficit/hyperactivity disorder. Mol. Psychiatry 10 (2005) 1126-1132
176. Walther D.J., and Bader M. A unique central tryptophan hydroxylase isoform. Biochem. Pharmacol. 66 (2003) 1673-1680
177. Wang Y., Wang Z., Yao K., Tanaka K., Yang Y., Shirakawa O., and Maeda K. Lack of association between the dopamine transporter gene 3′ VNTR polymorphism and attention deficit hyperactivity disorder in Chinese Han children: case-control and family-based studies. Kobe J. Med. Sci. 53 (2008) 327-333
178. Wood A.C., Rijsdijk F., Asherson P., and Kuntsi J. Hyperactive-impulsive symptom scores and oppositional behaviours reflect alternate manifestations of a single liability. Behav. Genet (2009)
179. Yan T., McQuillin A., Thapar A., Asherson P., Hunt S., Stanford S., and Gurling H. NK1 (TACR1) receptor gene 'knockout' mouse phenotype predicts genetic association with ADHD. J. Psychopharmacol (2009)
180. Yang J.W., Jang W.S., Hong S.D., Ji Y.I., Kim D.H., Park J., Kim S.W., and Joung Y.S. A case-control association study of the polymorphism at the promoter region of the DRD4 gene in Korean boys with attention deficit-hyperactivity disorder: evidence of association with the -521 C/T SNP. Prog. Neuropsychopharmacol. Biol. Psychiatry 32 (2008) 243-248
181. Zametkin A., Rapoport J.L., Murphy D.L., Linnoila M., and Ismond D. Treatment of hyperactive children with monoamine oxidase inhibitors. I. Clinical efficacy. Arch. Gen. Psychiatry 42 (1985) 962-966
182. Zametkin A.J., Nordahl T.E., Gross M., King A.C., Semple W.E., Rumsey J., Hamburger S., and Cohen R.M. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N. Engl. J. Med. 323 (1990) 1361-1366
183. Zhou K., Chen W., Buitelaar J., Banaschewski T., Oades R.D., Franke B., Sonuga-Barke E., Ebstein R., Eisenberg J., Gill M., Manor I., Miranda A., Mulas F., Roeyers H., Rothenberger A., Sergeant J., Steinhausen H.C., Lasky-Su J., Taylor E., Brookes K.J., Xu X., Neale B.M., Rijsdijk F., Thompson M., Asherson P., and Faraone S.V. Genetic heterogeneity in ADHD: DAT1 gene only affects probands without CD. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B (2008) 1481-1487
184. Zhou K., Dempfle A., Arcos-Burgos M., Bakker S.C., Banaschewski T., Biederman J., Buitelaar J., Castellanos F.X., Doyle A., Ebstein R.P., Ekholm J., Forabosco P., Franke B., Freitag C., Friedel S., Gill M., Hebebrand J., Hinney A., Jacob C., Lesch K.P., Loo S.K., Lopera F., McCracken J.T., McGough J.J., Meyer J., Mick E., Miranda A., Muenke M., Mulas F., Nelson S.F., Nguyen T.T., Oades R.D., Ogdie M.N., Palacio J.D., Pineda D., Reif A., Renner T.J., Roeyers H., Romanos M., Rothenberger A., Schafer H., Sergeant J., Sinke R.J., Smalley S.L., Sonuga-Barke E., Steinhausen H.C., van der Meulen E., Walitza S., Warnke A., Lewis C.M., Faraone S.V., and Asherson P. Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B (2008) 1392-1398